Details Basic Details Approval Date Thursday, June 25, 2020 Health Outcome(s) adverse pregnancy and fetal outcomes, valvular heart disease, pulmonary arterial hypertension Regulatory Link(s) (2) ARIA Memo FDA Approval Package